Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PMN ProMIS Neurosciences Inc

0,778

-0,002 (-0,26%)

Zuletzt aktualisiert: 16:48:30

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

ProMIS Neurosciences (NASDAQ:PMN)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more ProMIS Neurosciences Charts.

ProMIS Neurosciences (NASDAQ:PMN)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more ProMIS Neurosciences Charts.

News ProMIS Neurosciences Inc

ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
Dienstag 11 März 2025 (5 Stunden vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 25 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease
Dienstag 25 Februar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 19 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 14 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 12 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference
Mittwoch 29 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 27 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

ProMIS Neurosciences Issues Letter to Shareholders
Montag 13 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 10 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
Freitag 10 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 8 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Weitere ProMIS Neurosciences Inc News-Artikel

Saudi.araba 30r

China Renaissance (PK)

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen